CTOs on the Move

Nursefinders of Indianapolis

www.nfindy.com

 
Nursefinders of Indianapolis is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.nfindy.com
  • 8925 N Meridian St Ste 100
    Indianapolis, IN USA 46260
  • Phone: 317.818.4400

Executives

Name Title Contact Details

Similar Companies

Intrim Health Care

Intrim Health Care is a Cedar Bluff, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

California Hospital Association

At California Hospital Association (CHA), we collaborate with our members to provide strong and effective representation and advocacy to advance the interests of California hospitals, patients and communities. CHA is a trusted resource, working with members to achieve legislative, regulatory, and legal accomplishments at the state and federal level. Based in Sacramento, CHA is the statewide leader representing the interests of more than 400 hospitals and health systems in California.

Indiana Health Information Exchange

Indiana Health Information Exchange operates the nation’s largest health information exchange, providing a secure, robust and interoperable health information technology network that connects over 100 hospitals, long-term care facilities, rehabilitation centers, community health clinics and other healthcare providers. IHIE provides the nation’s largest implementation of clinical results delivery in the country (DOCS4DOCS® Service). The organization supports the Indiana Network for Patient Care, a clinical data repository accessed via IHIE’s CareWeb application. IHIE also provides Public Health, Transitions of Care and Population Health Management Services.

MetaWorks

MetaWorks is a Medford, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Symbiomix Therapeutics

Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.